Harvest One Cannabis Inc. (TSXV:HVST) (“Harvest One” or the “Company“) would like to provide clarification to shareholders in relation to both the Canadian Securities Administrators (“CSA“) staff notice 51-352 — Issuers with U.S. Marijuana-Related Activities and the Toronto Stock Exchange (“TSX“) guidance on Section 306, Section 325 and Part VII of the TSX company manual, issued on Oct. 16, 2017.
Harvest One can confirm that the Company does not own assets or have any operations in the U.S. therefore comply with the TSX listing requirements. We are confident the announcement from the TSX will have no impact on our business or our shareholders.
About Harvest One Cannabis Inc. (TSX.V:HVST)
Harvest One controls operations across the entire cannabis value chain through three business units, with Harvest One serving as the umbrella company over horticultural arm United Greeneries and medical arm Satipharm AG. Each business is strategically located in favourable jurisdictions with supportive regulatory frameworks in place. United Greeneries has received a Canadian medicinal cannabis cultivation license, making Harvest One one of only a few companies globally with the capacity to commercially cultivate cannabis in a federally regulated environment.
For more information about Harvest One, please contact:
+ 1 (778) 855-2408
Neither TSX-V nor its Regulation Services Provider (as that term is defined in the policies of the TSX-V) accepts responsibility for the adequacy or accuracy of this release.